Andreas Köberle: "Harnessing Lipidomics: Unveiling Innovative Biogenic Agents against Cancer and Inflammation"

15.00 Uhr

Prof. Dr. Andreas Köberle, Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), Universität Innsbruck

"Harnessing Lipidomics: Unveiling Innovative Biogenic Agents against Cancer and  Inflammation"
Seminar series TRR 305 - Striking a moving target: From mechanisms of metastatic organ colonisation to novel systemic therapies

Hybrid (Präsenz in Erlangen, Hörsaal TRC, Raum 0.010, Universität Erlangen)

Zoom-link, Nicht-Mitglieder des TRR 305 kontaktieren bitte: wencke.wallusch@fau.de